
Tyra Biosciences, Inc. — Investor Relations & Filings
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company specializes in therapies targeting fibroblast growth factor receptor (FGFR) biology, aiming to overcome tumor resistance and address key drivers of disease. Utilizing its proprietary SNÅP Discovery Engine, Tyra Biosciences designs innovative molecular structures. Its lead clinical program involves the development of oral dabogratinib for the treatment of skeletal dysplasia and urologic cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-05-13 | English | |
| 8-K - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-05-13 | English | |
| ARS - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-04-17 | English | |
| DEF 14A - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-04-17 | English | |
| 8-K - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-04-17 | English | |
| 8-K - Tyra Biosciences, Inc. (0001863127) (Filer) | 2026-04-02 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GI Innovation Inc.
Researches and develops protein-based drugs for immuno-onco…
|
358570 | KR | Professional, scientific and te… |
|
Ginkgo Bioworks Holdings, Inc.
Operates a horizontal platform for cell programming and syn…
|
DNA | US | Professional, scientific and te… |
|
GRAIL, Inc.
A healthcare company developing blood tests for multi-cance…
|
GRAL | US | Professional, scientific and te… |
|
GT Biopharma, Inc.
Clinical-stage immuno-oncology company developing therapies…
|
GTBP | US | Professional, scientific and te… |
|
Guard Therapeutics International AB
Clinical-stage biotech developing therapies to prevent acut…
|
GUARD | SE | Professional, scientific and te… |
|
Gubra A/S
Biotech and CRO focused on peptide drugs for metabolic and …
|
GUBRA | DK | Professional, scientific and te… |
|
HALOZYME THERAPEUTICS, INC.
Biopharmaceutical firm licensing technology to convert IV d…
|
HALO | US | Professional, scientific and te… |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Provides integrated R&D and manufacturing services for chem…
|
301096 | CN | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co., Ltd.
Leading global Contract Research Organization (CRO) for ful…
|
3347 | HK | Professional, scientific and te… |
|
Hangzhou Tigermed Consulting Co.,Ltd.
Provides clinical research solutions for pharmaceutical, bi…
|
300347 | CN | Professional, scientific and te… |
Tyra Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32575/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32575 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32575 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32575 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32575}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tyra Biosciences, Inc. (id: 32575)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.